药物数量(包括他汀类或二甲双胍使用)与老年人流感疫苗反应无关
本研究对542名65岁及以上、在2015-2018年四个流感季节随机接种标准剂量或高剂量流感疫苗的参与者进行二次分析,发现药物使用总体上与疫苗反应无关,但在糖尿病患者中,二甲双胍使用者的高剂量疫苗增强效应显著减弱(最大红细胞凝集抑制试验反应 p=0.002)。
要点
- 在老年人中,药物数量及他汀类或二甲双胍使用总体上与流感疫苗抗体反应无关。
- 糖尿病患者中,二甲双胍使用者的高剂量疫苗增强效应较非使用者显著减弱(p=0.002)。
- 该减弱效应在针对季节性A/H3N2(p=0.007)和B(p=0.03)抗原的反应中亦可见。
核心结论
- 老年人疫苗反应随药物使用变化很小,但研究提示二甲双胍可能与糖尿病患者中高剂量疫苗反应降低相关。
研究设计与样本
- 对542名65岁及以上、在2015-2018年四个流感季节随机接种标准剂量或高剂量流感疫苗的参与者数据进行二次分析。
- 药物计数及他汀类和二甲双胍使用为自我报告。
- 采用混合模型线性回归估计疫苗抗体滴度反应与药物使用之间的关联。
主要发现
- 参与者报告用药中位数为5种,45%(n=244)使用他汀类,12%(n=65)使用二甲双胍。
- 药物使用随衰弱、慢性病数量及男性而更高。
- 数据表明药物使用与疫苗反应无广泛关联,在调整衰弱和慢性病数量后以及在性别和疫苗剂量分层内分析时仍如此。
- 在糖尿病患者中,二甲双胍使用者(n=64)较非使用者(n=30)的高剂量疫苗强增强效应显著减弱,但仍略高于标准剂量反应。
- 该减弱效应在所有抗原特异性反应合并分析(即maxRBA,p=0.002)以及针对季节性A/H3N2(p=0.007)和B(p=0.03)抗原的反应中可见。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vaccination helps prevent infections and associated sequelae, especially in older adults. Since the degree to which vaccine responses are influenced by medications is not well described, we examined the association of medication count, including statin or metformin use, with influenza vaccine responsiveness. METHODS: A secondary analysis of data from 542 participants aged 65 years and older randomized to receive either the standard or high dose vaccine during four influenza seasons (2015-2018) was conducted. Medication counts, as well as statin and metformin usage, were self-reported. Associations between vaccine antibody titer responses and medication usage were estimated using mixed model linear regression. RESULTS: Participants reported taking a median of five medications, with 45 % (n = 244) of participants using a statin and 12 % (n = 65) metformin. Medication use was higher with frailty, chronic condition count and in males. Our data showed that medication use was not broadly associated with vaccine responsiveness, which held after adjusting for frailty and number of chronic conditions, and when investigated within sex and vaccine dose strata. However, within diabetics, the strong boosting effect of the high-dose vaccine was significantly dampened for metformin users (n = 64) as compared to non-users (n = 30), but still remained slightly higher than standard-dose responses. This dampening effect was evident in analyses where all antigen-specific responses were combined (i.e. maxRBA, p = 0.002), and for responses against seasonal A/H3N2 (p = 0.007) and B (p = 0.03) antigens. CONCLUSION: Vaccine responses varied little with medication usage among older adults. However, our findings suggest metformin may be associated with reductions in the high-dose vaccine response within diabetics.
引用
- Li V, McClure H, Patel R, et al. Medication count, including statin or metformin use, is not associated with influenza vaccine responses in older adults. Vaccine. 2025. PMID: 41167013. doi:10.1016/j.vaccine.2025.127913
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。